Clinical observation of pneumomediastinum in a case of severe COVID-19-associated pneumonia in a teenager
https://doi.org/10.36604/1998-5029-2022-85-108-115
Abstract
Aim. Demonstration of the clinical case of pneumomediastinum in a teenager with severe COVID-19- associated pneumonia.
Materials and methods. The clinical case of spontaneous pneumomediastinum was presented, which was a complication of the severe course of COVID-19 pneumonia in a teenager.
Results. Patient Ch., 15 years old, with obesity of the 1st degree, was admitted to the hospital of infectious diseases for patients with a COVID-19 on the 7th day of the illness in a severe condition and had complaints of an increase in body temperature to 40ºC, pronounced cough and weakness, dyspnea when walking and at rest. The PCR test for SARS-CoV-2 gave a positive result. Multispiral computed tomography showed polysegmental interstitial lesion of both lungs, which had multiple areas of “ground glass”, signs of pneumomediastinum, subcutaneous emphysema of the upper third of the chest, left-sided pleural effusion. The volume of lung tissue lesion was 50% on the right and 85% on the left. The positive effect of treatment was not observed after 2-3 days in the hospital. The condition of heavy severity continued due to intoxication syndrome, respiratory failure, inflammatory changes in lung tissue syndrome. In this regard, the patient was injected intravenously with tocilizumab (Actemra®) 400 mg. The child was released on the 20th day of hospitalization with a positive clinical effect.
Conclusion. The above clinical case demonstrates that in children a novel coronavirus infection can occur not only in severe form, but also with the possible development of complications in the form of pneumomediastinum and low effectiveness of antibacterial and antiviral therapy, which required the use of humanized monoclonal antibodies (tocilizumab).
About the Authors
E. V. KnizhnikovaRussian Federation
Elena V. Knizhnikova, MD, Staff Scientist of Molecular Genetic Diagnosis Group
49/1 Voronezhskaya Str., Khabarovsk, 680022
213 Tikhookeanskaya Str., Khabarovsk, 680033
G. P. Evseeva
Russian Federation
Galina P. Evseeva, MD, PhD, DSc (Med.), Deputy Director on Scientific Work, Main Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health
49/1 Voronezhskaya Str., Khabarovsk, 680022
S. A. Cherezov
Russian Federation
Sergey A. Cherezov, MD, Radiologist
213 Tikhookeanskaya Str., Khabarovsk, 680033
T. M. Adlivankina
Russian Federation
Tamara M. Adlivankina, MD, Pulmonologist, Head of Infectious Department number 2
213 Tikhookeanskaya Str., Khabarovsk, 680033
R. S. Telepneva
Russian Federation
Regina S. Telepneva, MD, Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health
49/1 Voronezhskaya Str., Khabarovsk, 680022
S. V. Suprun
Russian Federation
Stefania V. Suprun, MD, PhD, DSc (Med.), Main Staff Scientist of the Group of Health and Environmental Problems of Mother and Child Health
49/1 Voronezhskaya Str., Khabarovsk, 680022
O. A. Lebedko
Russian Federation
Olga A. Lebed’ko, MD, PhD, DSc (Med.), Director
49/1 Voronezhskaya Str., Khabarovsk, 680022
References
1. Alexandrovich Yu.S., Alekseeva E.I., Bakradze M.D., Baranov A.A., Batysheva T.T., Vashakmadze N.D., Vershinina M.G., Vishneva E.A., Glazyrina A.A., Gordeeva O.B., Dyakonova E.Yu., Zholobova Е.S., Zabolotsky D.V., Zvereva N.N., Zelenkova I.V., Ivanov D.O., Kaytukova E.V., Karkashadze G.A., Konovalov I.V., Kruchko D.S., Kulichenko T.V., Kurbanova S.K., Levina Y.G., Lobzin Yu.V., Mazankova L.N., Margieva T.V., Namazova-Baranova L.S., Novikova Yu.Yu., Ovsyannikov D.Yu., Petryaykina E.E., Petrenko Yu.V., Petrova N.V., Prometnoy D.V., Pshenisov K.V., Revunenkov G.V., Rtishchev A.Yu., Rusinova D.S., Sayfullin M.A., Sayfullin R.F., Selimzyanova L.R., Tatochenko V.K., Tepaev R.F., Uskov A.N., Fedoseenko M.V., Fisenko A.P., Khar’kin A.V., Efendieva K.E., Yakovlev A.V. [Clinical Features and Management of the Disease Caused by New Coronaviral Infection (COVID-19) in Children. Version 2.]. Pediatric pharmacology 2020; 17(3):187−212 (in Russian). https://doi.org/10.15690/pf.v17i3.2123
2. Evseeva G.P., Telepneva R.S., Knizhnikova E.V., Suprun S.V., Pichugina S.V., Yakovlev E.I., Galyant O.I., Kozlov V.K., Lebed’ko O.A. [COVID-19 in pediatric population]. Bûlleten' fiziologii I patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2021; (80):100–114 (in Russian). https://doi.org/10.36604/1998-5029-2021-80-100-114
3. Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs B.J., Ross C.E., McKiernan C.A., Heidemann S.M., Kleinman L.C., Sen A.I., Hall M.W., Priestley M.A., McGuire J.K., Boukas K., Sharron M.P., Burns J.P. Characteristics and Outcomes of Children With Coronavirus Disease 2019(COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatrics 2020; 174(9):868–873. https://doi.org/10.1001/jamapediatrics.2020.1948
4. Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., Tong S. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics 2020; 145(6):e20200702. https://doi.org/10.1542/peds.2020-0702
5. Mazankova L.N., Osmanov I.M., Samitova E.R., Malakhov A.B., Koroid V.V., Nedostoev А.A., Kaurova E.P., Kuznetsova T.A., Kulichkina O.S., Loban N.V. A teenager with a severe form of COVID-19. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2020; 65(5):58−65 (in Russian). https://doi.org/10.21508/1027-4065-2020-65-5-58-65
6. Polyantsev A.A, Panin S.I., Polyantsev A.A.(Jr), Kotrunov V.V. Pneumomediastinum in patients with a novel coronavirus infection (COVID-19). Pirogov Russian Journal of Surgery = Khirurgiya. Zurnal im. N.I. Pirogova 2021; (5):20–24 (in Russian). https://doi.org/10.17116/hirurgia202105120
7. Wadhawa R., Thakkar A., Chhanwal H.S., Bhalotra A., Rana Y., Wadhawa V. Spontaneous pneumomediastinum and subcutaneous emphysema in patients with COVID-19. Saudi J. Anaesth. 2021; 15(2):93–96. https://doi.org/10.4103/sja.SJA_939_20
8. Protrka M.R., Ivanac G., Dudanc L., Vujevic F., Brkljacic B. Spontaneous pneumomediastinum, pneumothorax and subcutaneous emphysema: radiological aspects of rare COVID-19 complications in three patients. Radiol. Case Rep. 2021; 16(11):3237–3243. https://doi.org/10.1016/j.radcr.2021.07.089
9. Mohan V., Tauseen R.A. Spontaneous pneumomediastinum in COVID-19. BMJ Case Rep. 2020; 13(5):e236519. https://doi.org/10.1136/bcr-2020-236519
10. Goldman N., Ketheeswaran B., Wilson H. COVID-19-associated pneumomediastinum. Clin. Med. (Lond.) 2020; 20(4):e91–e92. https://doi.org/10.7861/clinmed.2020-0247
11. Zhou C., Gao C., Xie Y. COVID-19 with spontaneous pneumomediastinum. Lancet Infect. Dis. 2020; 20(4):510. https://doi.org/10.1016/S1473-3099(20)30156-0
12. Joshi S., Bhatia A., Tayal N., Chaturvedi S., Ali S.J. Alveolar Air Leak Syndrome a Potential Complication of COVID-19-ARDS – Single Center Retrospective Analysis. J. Assoc. Physicians India 2021; 69(1):22–26. PMID: 34227771
13. Macklin M.T., Macklin C.C. Malignant interstitial emphysema of the lungs and mediastinum as an important occult complication in many respiratory diseases and other conditions: interpretation of the clinical literature in the light of laboratory experiment. Medicine1944; 23(4):281–358.
14. Lesteva N.А., Аdieva E.V., Lesina S.S., Аibazova M.I., Аbramov K.B., Sebelev K.I., Kondratiev А.N. COVID- 19 Pneumonia Pneumomediastinum. Clinical Cases. Messenger of Anesthesiology and Resuscitation 2021; 18(3):23–29 (in Russian). https://doi.org/10.21292/2078-5658-2021-18-3-23-29
Review
For citations:
Knizhnikova E.V., Evseeva G.P., Cherezov S.A., Adlivankina T.M., Telepneva R.S., Suprun S.V., Lebedko O.A. Clinical observation of pneumomediastinum in a case of severe COVID-19-associated pneumonia in a teenager. Bulletin Physiology and Pathology of Respiration. 2022;(85):108-115. (In Russ.) https://doi.org/10.36604/1998-5029-2022-85-108-115